Málaga, Spain

Monica Alonso Scrignoli


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Monica Alonso Scrignoli: Innovator in GLP-1 Peptide Receptor Modulation

Introduction

Monica Alonso Scrignoli is a prominent inventor based in Málaga, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of drugs that target the GLP-1 peptide receptor. Her innovative work aims to address various health issues, including obesity and diabetes.

Latest Patents

Monica holds a patent for "1,2,4-oxadiazole derivatives as drugs modulating the GLP-1 peptide receptor." This invention relates to the use of a compound of formula (I) or a pharmaceutically acceptable solvate or salt thereof in the preparation of a medicinal product. The focus of her patent is on the prevention and treatment of diseases where the GLP-1 receptor plays a crucial role, such as eating disorders, obesity, anorexia, lipid dysfunction, diabetes, hyperinsulinism, cardiovascular diseases, and metabolic syndrome. She has 1 patent to her name.

Career Highlights

Monica Alonso Scrignoli is associated with Vivia Biotech S.L., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving health outcomes through innovative drug design.

Collaborations

Monica collaborates with notable professionals in her field, including Fernando Rodríguez De Fonseca and Miguel Romero Cuevas. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Monica Alonso Scrignoli is a trailblazer in the field of medicinal chemistry, with a focus on GLP-1 peptide receptor modulation. Her contributions are vital in the fight against various metabolic diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…